672 results on '"Lacour, Jean‐Philippe"'
Search Results
2. A long-term, prospective, observational cohort study of the safety and effectiveness of etanercept for the treatment of patients with paediatric psoriasis in a naturalistic setting
3. IgE Depletion with Ligelizumab Does Not Significantly Improve Clinical Symptoms in Patients with Moderate-to-Severe Atopic Dermatitis
4. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial
5. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
6. Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial)
7. Targeting immunoglobulin E in atopic dermatitis: A review of the existing evidence
8. Improvement of patient outcomes following therapeutic optimization of chronic urticaria: two-year data from France as part of the international real-life AWARE study
9. Apremilast in Combination with Narrowband UVB in the Treatment of Vitiligo: A 52-Week Monocentric Prospective Randomized Placebo-Controlled Study
10. Efficacy of Apremilast in Patients with Moderate-to-Severe Genital Psoriasis: Body Surface Area Subgroup Results from the Phase 3 DISCREET Trial
11. EFFICACY AND SAFETY OF APREMILAST IN PATIENTS WITH MODERATE-TO-SEVERE GENITAL PSORIASIS: RESULTS FROM DISCREET, A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
12. Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL)
13. Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)
14. Caspase 1/11 Deficiency or Pharmacological Inhibition Mitigates Psoriasis-Like Phenotype in Mice
15. Evaluation of Children with Psoriasis from the BiPe Cohort: Are Patients Using Biotherapies in Real Life Eligible for Phase III Clinical Studies?
16. Nivolumab-Induced Pneumonitis in Patient With Metastatic Melanoma Showing Complete Remission on 18F-FDG PET/CT
17. Efficacy and Safety of Apremilast in Patients With Genital Psoriasis: Results From the Phase 3, Randomized, Placebo-Controlled, Double-blind DISCREET Study
18. Clinicopathologic and molecular analyses of cutaneous leiomyosarcoma: A retrospective, multicenter study of 79 cases
19. Étude échographique des enthèses chez des patients porteurs d’un psoriasis avec ou sans signes ostéoarticulaires : étude prospective
20. Ultrasound study of entheses in psoriasis patients with or without musculoskeletal symptoms: A prospective study
21. Clinical Features, Histological Characteristics, and Disease Outcomes of Mycosis Fungoides in Children and Adolescents: A Nationwide Multicentre Cohort of 46 Patients
22. Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial
23. Interleukin-33 antibody failed to demonstrate benefit in a phase II, double-blind, randomized, placebo-controlled study in adult patients with moderate-to-severe atopic dermatitis
24. Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Compared with Betamethasone 17-Valerate-Medicated Plaster for the Treatment of Psoriasis
25. A Randomized, Investigator-Masked, Double-Blind, Placebo-Controlled Trial on Thalidomide in Severe Cutaneous Sarcoidosis
26. 33124 Severe infections, confirmed extended major adverse cardiovascular events, and malignancies over 5 years of treatment with tildrakizumab in terms of number needed to harm: Pooled analyses from the reSURFACE 1 and reSURFACE 2 phase 3 trials
27. 33307 Nemolizumab is associated with a rapid reduction of itch and sleep disturbance in patients with prurigo nodularis
28. Clinical Outcomes of Metastatic Melanoma Treated With Checkpoint Inhibitors and Multisite Radiotherapy
29. Treatment of Elastosis Perforans Serpiginosa Using a Fractional Carbon Dioxide Laser
30. Anti‐BP180 IgG antibody ELISA values correlate with adverse pregnancy outcomes in pemphigoid gestationis.
31. Multicenter prospective observational study of dupilumab‐induced ocular events in atopic dermatitis patients.
32. Mise en place d’un secteur de pathologie moléculaire en oncologie au sein d’un laboratoire d’anatomie pathologique (LPCE, CHU de Nice)
33. Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK Signaling
34. The scalp hair collar and tuft signs: A retrospective multicenter study of 78 patients with a systematic review of the literature
35. Posterior reversible encephalopathy syndrome due to combination of vemurafenib and cobimetinib for metastatic melanoma
36. Interleukin 6 and high-sensitivity C-reactive protein are potential predictive markers of response to infliximab in hidradenitis suppurativa
37. A long-term, prospective, observational cohort study of the safety and effectiveness of etanercept for the treatment of patients with paediatric psoriasis in a naturalistic setting.
38. Clinical Features, Histological Characteristics, and Disease Outcomes of Mycosis Fungoides in Children and Adolescents: A Nationwide Multicentre Cohort of 46 Patients.
39. Efficacy of an Innovative Aerosol Foam Formulation of Fixed Combination Calcipotriol plus Betamethasone Dipropionate in Patients with Psoriasis Vulgaris
40. Le signe dermoscopique de la “tache d’encre” marqueur de l’invasion folliculaire des naevus congénitaux du cuir chevelu
41. Changements (« switchs ») de biothérapies dans le psoriasis de l’enfant : résultats de la cohorte BiPe
42. Étude observationnelle multicentrique française prospective de survenue d’effets indésirables ophtalmologiques chez les patients traités par dupilumab pour une dermatite atopique. Étude DUPI ŒIL
43. Aspects cliniques, histologiques et moléculaires des léiomyosarcomes cutanés : étude rétrospective, multicentrique sur 79 patients
44. Long-Term Improvements Observed in Tralokinumab-Treated Patients with Moderate-to-Severe Atopic Dermatitis: an ECZTEND Interim Analysis
45. Prognosis and response to laser treatment of early-onset hypertrophic port-wine stains (PWS)
46. Fractionated Bipolar Radiofrequency and Bipolar Radiofrequency Potentiated by Infrared Light for Treating Striae: A Prospective Randomized, Comparative Trial With Objective Evaluation
47. Spectrum of Clinical Responses to Therapies in Infantile Bullous Pemphigoid
48. Pigmented macules of bony prominences (PMBP): A distinct presentation in patients with red hair
49. Comparative Methods for Improving Transepidermal Methylaminolevulinate Delivery: A Randomized Clinical Trial
50. Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.